Larson SM - Search Results

1

Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.

Robbins RJ, Srivastava S, Shaha A, Ghossein R, Larson SM, Fleisher M, Tuttle RM. Robbins RJ, et al. Among authors: larson sm. J Clin Endocrinol Metab. 2004 Dec;89(12):6010-6. doi: 10.1210/jc.2003-031573. J Clin Endocrinol Metab. 2004. PMID: 15579752

2

Thyroid cancer dosimetry using clearance fitting.

Furhang EE, Larson SM, Buranapong P, Humm JL. Furhang EE, et al. Among authors: larson sm. J Nucl Med. 1999 Jan;40(1):131-6. J Nucl Med. 1999. PMID: 9935068 Free article.

3

[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.

Wang W, Macapinlac H, Larson SM, Yeh SD, Akhurst T, Finn RD, Rosai J, Robbins RJ. Wang W, et al. Among authors: larson sm. J Clin Endocrinol Metab. 1999 Jul;84(7):2291-302. doi: 10.1210/jcem.84.7.5827. J Clin Endocrinol Metab. 1999. PMID: 10404792

4

Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue.

Robbins RJ, Hill RH, Wang W, Macapinlac HH, Larson SM. Robbins RJ, et al. Among authors: larson sm. Thyroid. 2000 Feb;10(2):177-83. doi: 10.1089/thy.2000.10.177. Thyroid. 2000. PMID: 10718556

5

Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, Yeung H, Macapinlac H, Rosai J, Robbins RJ. Wang W, et al. Among authors: larson sm. J Clin Endocrinol Metab. 2000 Mar;85(3):1107-13. doi: 10.1210/jcem.85.3.6458. J Clin Endocrinol Metab. 2000. PMID: 10720047 Clinical Trial.

6

Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients.

Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ. Pittas AG, et al. Among authors: larson sm. Thyroid. 2000 Mar;10(3):261-8. doi: 10.1089/thy.2000.10.261. Thyroid. 2000. PMID: 10779141

7

Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry.

Yeung HW, Humm JL, Larson SM. Yeung HW, et al. Among authors: larson sm. J Nucl Med. 2000 Jun;41(6):1082-5. J Nucl Med. 2000. PMID: 10855639 Free article.

8

Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates.

Tickoo SK, Pittas AG, Adler M, Fazzari M, Larson SM, Robbins RJ, Rosai J. Tickoo SK, et al. Among authors: larson sm. Arch Pathol Lab Med. 2000 Oct;124(10):1440-7. doi: 10.5858/2000-124-1440-BMFTC. Arch Pathol Lab Med. 2000. PMID: 11035572 Free article.

9

Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature.

Robbins RJ, Voelker E, Wang W, Macapinlac HA, Larson SM. Robbins RJ, et al. Among authors: larson sm. Endocr Pract. 2000 Nov-Dec;6(6):460-4. doi: 10.4158/EP.6.6.460. Endocr Pract. 2000. PMID: 11155220 Review.

10

Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma.

Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD. Robbins RJ, et al. Among authors: larson sm. J Clin Endocrinol Metab. 2001 Feb;86(2):619-25. doi: 10.1210/jcem.86.2.7189. J Clin Endocrinol Metab. 2001. PMID: 11158019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

684 results

Search Page

Filters